Glycosylated Hemoglobin as an Independent Prognostic Marker in COVID-19 Patients With Diabetes Mellitus

Objective The main objective of this study is to analyze the severity of coronavirus disease 2019 (COVID-19) among patients with diabetes mellitus using glycosylated hemoglobin (HbA1c) as a prognostic marker in predicting the outcome among these individuals. Methods This was a retrospective, observa...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalia, Gopakumar, Vaiera Manigandan, Alagesan Chellappillai, Rangabashyam, Seetharaman Ranganathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524717/
https://www.ncbi.nlm.nih.gov/pubmed/36196314
http://dx.doi.org/10.7759/cureus.28634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524717/
https://www.ncbi.nlm.nih.gov/pubmed/36196314
http://dx.doi.org/10.7759/cureus.28634

Ejemplares similares